מצגות וכנסים

מצגות מכנס הקיץ של החברה הישראלית לחקר הכבד

13-15 ביוני 2019 | מלון דן, אילת

פתיחה: נתונים כלליים

לחשוב על מה שקל – לא עזר
ד"ר אבו-מוך סייף, פנימית ב', המרכז הרפואי הלל יפה

הפטיטיס אוטואימונית - להפוך את הקערה על פיה!
ד"ר טארק סעדי, רמב"ם

אם הכבד אינו מסנן את הדם...מי כן?
Yana Davidov, Liver Diseases Center, Sheba Medical Center

To B or not to B - What is the Answer
ד"ר דוד ירדני, המכון לגסטרואנטרולוגיה ומחלות כבד, מרכז רפואי סורוקה

A Heart Touching Case
Yaakov Maor, M.D, Kaplan Medical Center, Rehovot

COMMD10 drives resolution of acetaminophen-induced liver injury by promoting Kupffer cell-governed clearance of dying cells
Keren Cohen

Alcoholic Liver Disease – Role of the Metabolic Syndrome
Cohen Mendel L, Sharabi-Kriger O, Melzer E, Malnick SDH, Maor Y, Kaplan Medical Center, Rehovot

Chronic amiodarone administration induces pancreatic, adipose tissue and hepatic damage
Hubel E, Houri I, Avraham R, Zvibel I, Shibolet O. Gastroenterology Institute, Tel-Aviv Sourasky Medical Center, affiliated with Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel

Farnesoid X receptor (FXR) agonists inhibited Sodium taurocholate co-transporting polypeptide (NTCP) and accelerated activated hepatic stellate cells apoptosis
Ahmad Salhab, Johnny Amer, Rifaat Safadi,The Liver Unit, Hadassah Hebrew University Hospital; Jerusalem

Exosomes Secreted by Hepatocytes can Inhibit and Reverse the Development of Hepatic Fibrosis In-Vivo
Safran Michal, Masoud Rula, Sultan Maya, Tachlytski Irena,Pery Ron, Balint-Lahat Nora, Pappo Orit, Ben-Ari Ziv
Liver Disease Center, Chaim Sheba Medical Center Tel-Hashomer, Pathology Department, Chaim Sheba Medical Center Tel-Hashomer Department of general surgery, Chaim Sheba Medical Center Tel-Hashomer; Sackler School of Medicine, Tel Aviv University

Hepatic Fibrosis progression among HIV patients in Israel
Karen Olshtain-Pops, Adir Ben Nachum, Rifaat Safadi, Department of Infectious Diseases and The Liver Unit Hadassah Medical Organization & Faculty of medicine The Hebrew University, Jerusalem, Israel

Leukemia inhibitory factor (LIF) corrects the impaired bile duct morphogenesis in sortilin-deficient mice in cholestatic liver injury
Hubel E, Zvibel I, Shibolet O. Gastroenterology Institute, Tel-Aviv Sourasky Medical Center, affiliated with Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel

Yttrium-90 Radioembolization for the Treatment of Hepatocellular Carcinoma-single center experience
Meringer Hadar, Menachem Yoram, Kori Isaac, Shibolet Oren
Department of Gastroenterology and Hepatology, Tel Aviv Sourasky Medical Center, Unit of Angiography, Division of Radiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel

ILC 2019 - Toxic and alcoholic liver injury
ד"ר מיכל כהן

Homozygosity for the PNPLA3 I148M and not for TM6SF2 E167K Polymorphisms Influences Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease: A single center study in Israel
Davidov Yana, Cohen-Ezra Oranit, Lichter Maria, Yehuda-Margalit Reuma, Albshesh Ahmad, Abu-Baker Fadi, Zilbergberg Dana, Ivanovsky Lidia, Hassid Avishag, Tzaraf Keren, Michal Safran, Landesman Hadas, Chai Chofit, Tachlytski Irina, Ben-Ari Ziv
Liver Diseases Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Sackler School of Medicine, Tel Aviv University, Israel

Non-Alcoholic Fatty Liver Disease in the Galilee showed an RBC importance
Hamza Atia, Johnny Amer & Rifaat Safadi, Holy Family Hospital, Nazareth, Hadassah Medical Center, Jerusalem

Should we change allocation policy for NASH patients?
Assaf Issachar, Sigal Cohen, Eytan Mor, Michal Cohen-Naftaly, Orly Sneh-Arbib, Amir Shlomai, Noam Peleg, Rachel Michowiz, Ran Tur Kaspa, Eviatar Nesher, Marius Braun
Liver institute and transplantation department- Rabin Medical Center-Beilinson hospital

High Interest but Low Compliance to a Nonalcoholic Fatty Liver Disease (NAFLD) Facebook Campaign
Yael Milgrom, Eliana Mashraki, Yana Markovich Ovad, Suha Sandoka, Muhammad Massarwa, Mina Rowe, Tova Nesher and Rifaat Safadi

Prevalence of elevated hepatocellular liver enzymes in obese/overweight Israeli children and adolescents
Corina Hartman, Igal Elenberg, Gadi Rennert, Eli Zuckerman
Pediatric GI Unit, Epidemiology Department and Liver Unit, Carmel Medical Center

HCV elimination in France
Victor de Lédinghen MD PhD, CHU Bordeaux, France

Elimination of HCV in HIV-HCV co-infected Patients
Practical Strategies

Hepatitis C virus screening among former USSR immigrants presenting to the larger urban Emergency Department in Israel: A low screening rate*
Ivanovski L, Silverberg D, Irony A, Epstein A, Tzaraf K, Hassid A,
Ben–Ari Z, Liver Diseases Center, Emergency Room, Sheba Medical Center, Ramat-Gan and The Sackler School of Medicine, Tel Aviv University, Israel

Circulation of hepatitis A in Israel 2017-2018: environmental surveillance supports clinical findings
Yael Gozlan, Itay Bar-Or, Hadar Volnowitz, Michal Savion, Rivka Rich, Emilia Anis, Ella Mendelson, Ziv Ben-Ari and Orna Mor
Central Virology Laboratory, Ministry of Health

Real World Evidence of the Effectiveness and Clinical Practice Use of Glecaprevir plus Pibrentasvir in Patients with Chronic Hepatitis C Genotypes 1 to 6 - Interim Analysis results from the INNOVATE study
Veitsman Ella, Cohen Michal, Carmiel-Haggai Michal, Rawi Hazzan, Lysenko Marina, Banayan Hilla, Schonbrun Miriam, Cohen Raanan
1 Center for Liver Diseases, Rambam Health Care Campus, Haifa, Israel
2 Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel
3 Department of Gastroenterology, Rabin Medical Center, Tel Aviv University, Beilinson Hospital, Tel Aviv 49100, Israel.
4 Liver unit, Galilee Medical center, Nahariya, Israel. The Azrieli Faculty of Medicine, Bar-Ilan University, Zefat, Israel.
5 Liver Unit, Haemek Medical Center, Afula, Israel.
6 ABBVIE BIOPHARMACEUTICALS LTD, Israel

When to stop NUC therapy in HBV?
Pietro Lampertico, MD PhD, Gastroenterology and Hepatology Division, Fondazione IRCCS Cà Granda - Ospedale Maggiore Policlinico, University of Milan

Hepatitis E-Not exactly what you thought. Updates from ILC2019
Orna Mor, Central Virology Laboratory' Ministry of Health

New treatment options for HBV and HDV
Pietro Lampertico, MD PhD, Gastroenterology and Hepatology Division, Fondazione IRCCS Cà Granda - Ospedale Maggiore Policlinico, University of Milan

EASL 2019 - best of Cirrhosis and its Complications
Ziv Ben-Ari, Liver Diseases Center, Sheba Medical Center

Interleukin 23 produced by hepatic monocyte-derived macrophages is essential for the development of primary biliary cholangitis
Debby Reuveni, PhD

The influence of Pediatric and Genetic Cholestatic Diseases on the Adult
Ronald J. Sokol, MD, FAASLD, Digestive Health Institute
Children’s Hospital Colorado, University of Colorado School of Medicine, Aurora, Colorado

The microbiome in PSC
Lapidot L, Amir A, Ben-Simon S, Bradichevsky T, Engel T, Weiss P, Veitsman E, Cohen-Ezra O, Davidov Y, Segev S, Koren O, Safran M, Ben-Ari Z1,
Liver research laboratory, Liver Diseases Center, The Sackler School of Medicine, Tel Aviv University, Tel Aviv, The Institute For Medical Screening Tel Hashomer, Faculty of Medicine, Bar-Ilan University,Safed, The cancer research center, Tel Hashomer

Intrahepatic Cholestasis of Pregnancy as a Risk Factor for Preeclampsia - Retrospective Case Control Study
Presented by: Dr. Orly Sneh Arbib, MD, Beilinson Hospital, Rabin Medical Center

Biliary Atresia - Advances in Etiology and Early Diagnosis
Ronald J. Sokol, MD, FAASLD, Pediatric GI, Hepatology, Nutrition, Digestive Health Institute, Children’s Hospital Colorado, University of Colorado School of Medicine

Best of ILC 2019 NAFLD
Shira Zelber-Sagi R.D. Ph.D, Dept. of Gastroenterology, Tel Aviv Medical Center, School of Public Health, Haifa University, Israel

Single cell RNA-seq reveals dendritic cell involvement in human and mouse NAFLD/NASH
Aleksandra Deczkowska, Assaf Weiner, Dominik Pfister, Baoguo Li, Bernard Malissen, Andreas Schlitzer, Florent Ginhoux, Mathias Heikenwälder, Michal Safran, Ziv Ben-Ari, Ido Amit

Glucose dependent insulinotrophic polypeptide (GIP), a new player in the combat against obesity and NAFLD
Dr. Irina Efimova, The Research Center for Digestive Tract & Liver Diseases, Sourasky Medical Center, Department of Clinical Microbiology & Immunology, Sackler School of Medicine, Tel-Aviv University, Under supervision of Dr. Sigal Fishman and Dr. Chen Varol

Portal hypertension may precede a clinically significant decline in liver synthetic tests among patients with severe non-alcoholic fatty liver disease
Dor Shirin, Noam Peleg, Shirley Yanay, Orly Sneh-Arbib, Michal Cohen-Naftaly, Marius Brown, Assaf Issachar, Amir Shlomai, Department of Medicine D, Rabin Medical Center, Beilinson hospital, Petah-Tikva, Israel, The Liver Institute, Rabin Medical Center, Beilinson hospital, Petah-Tikva, Israel,The Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel

High Fibrosis Scores Within Diabetology Clinics NAFLD Population
Soha , Sandouka, Mohammad Masarwa, Yael Milgrom, Jasmin Malabi, Rifaat Safadi, The Liver Unit, Hadassah Hebrew University Hospital; Jerusalem

Nonalcoholic Fatty Liver Disease`s all-cause of mortality is associated with the metabolic syndrome and the severity of liver disease in hospital admitted patients using Big Data Analytics
Oranit Cohen-Ezra, Ehud Grossman, Dina Vorobeichik, Miriam Gibli, Ziv Ben-Ari, Liver Diseases Center, Internal Medicine Department, Center of Innovation, Sheba Medical Center, and The Sackler School of Medicine, Tel-Aviv University, Israel

Hepatocyte specific sortilin deficiency increases hepatic steatosis and non-alcoholic steatohepatitis
Reicher R, Berman G, Hubel E, Avraham R, Shibolet O, Fishman S, Zvibel I, The Research Center for Digestive Tract and Liver Diseases, Sourasky Medical Center and Sackler School of Medicine, Tel-Aviv Universit

דוח כספי

נושאים קשורים:  מצגות וכנסים
תגובות